SPY383.63+6.93 1.84%
DIA315.24+5.66 1.83%
IXIC12,920.15+196.68 1.55%

EGENXBIO Announces Presentations At Angiogenesis, Exudation, And Degeneration 2021 Conference On Feb. 13

ROCKVILLE, Md., Feb. 5, 2021 /PRNewswire/ -- REGENXBIO Inc. (NASDAQ:RGNX) today announced that two oral presentations will be presented at the Angiogenesis, Exudation, and Degeneration 2021 conference taking

· 02/05/2021 07:07

ROCKVILLE, Md., Feb. 5, 2021 /PRNewswire/ -- REGENXBIO Inc. (NASDAQ:RGNX) today announced that two oral presentations will be presented at the Angiogenesis, Exudation, and Degeneration 2021 conference taking place virtually from February 12 to 13, 2021.

The presentations will be as follows:

Presentation Title: Subretinal Gene Therapy for Exudative AMD

Presenter: Allen C. Ho, M.D., Director of Retina Research at Wills Eye Hospital and Mid Atlantic Retina

Date/Time: Saturday, February 13, 2021, 9:15 a.m. ET

Presentation Title: Suprachoroidal Gene Therapy for Exudative AMD and Diabetic Retinopathy

Presenter: Peter A. Campochiaro, M.D., Director, Retinal Cell and Molecular Laboratory, Professor of Ophthalmology, The Wilmer Eye Institute, Johns Hopkins University School of Medicine

Date/Time: Saturday, February 13, 2021, 9:45 a.m. ET